IGC Pharma (IGC) FCF Margin Growth (5y) (2015 - 2025)
IGC Pharma (IGC) FCF Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
108,818.00 |
| Jun 30, 2025 |
41,312.00 |
| Mar 31, 2025 |
910,782.00 |
| Dec 31, 2024 |
15,174.00 |
| Sep 30, 2024 |
-11,435.00 |
| Jun 30, 2024 |
-41,279.00 |
| Mar 31, 2024 |
-10,842.00 |
| Dec 31, 2023 |
-70,738.00 |
| Sep 30, 2023 |
-52,908.00 |
| Jun 30, 2023 |
-23,171.00 |
| Mar 31, 2023 |
-82,203.00 |
| Dec 31, 2022 |
-62,602.00 |
| Sep 30, 2022 |
-58,775.00 |
| Jun 30, 2022 |
-10,232.00 |
| Mar 31, 2022 |
33,700.00 |
| Dec 31, 2021 |
-180,217.00 |
| Sep 30, 2021 |
-362,733.00 |
| Jun 30, 2021 |
-259,393.00 |
| Mar 31, 2021 |
-319,062.00 |
| Dec 31, 2020 |
-184,431.00 |
